Cargando…
Faut-il contrôler la fièvre dans les infections sévères ?
Temperature control during severe sepsis is currently used in intensive care and involves 66% and 70% of severe sepsis and septic shock, respectively. Nevertheless, the conclusive evidence of the benefit of such a strategy is still lacking.We might wonder, with regards to experimental works and rece...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lavoisier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117820/ https://www.ncbi.nlm.nih.gov/pubmed/32288743 http://dx.doi.org/10.1007/s13546-015-1168-x |
_version_ | 1783514449082056704 |
---|---|
author | Seguin, P. Launey, Y. Nesseler, N. Malledant, Y. |
author_facet | Seguin, P. Launey, Y. Nesseler, N. Malledant, Y. |
author_sort | Seguin, P. |
collection | PubMed |
description | Temperature control during severe sepsis is currently used in intensive care and involves 66% and 70% of severe sepsis and septic shock, respectively. Nevertheless, the conclusive evidence of the benefit of such a strategy is still lacking.We might wonder, with regards to experimental works and recent noninterventional studies, about the risk of a control strategy on an ongoing infectious process, the patient’s outcome, and the safety of the means implemented to obtain temperature control. On the other hand, it is also demonstrated that fever increases oxygen consumption, which may lead in some clinical situations to tissular ischemia and that fever may be associated with a deleterious focal inflammatory process. Methods to control the temperature include external and/or internal cooling and/or antipyretic medications such as paracetamol and nonsteroidal antiinflammatory drugs. In septic patients, external cooling and paracetamol are the mains means used to control temperature. Despite the uncertainties about the benefit to control or not the temperature, it could be stated that extreme temperature (hypo- or hyperthermia) should be avoided and that the benefit/risk of temperature control must be individually weighted. |
format | Online Article Text |
id | pubmed-7117820 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Lavoisier |
record_format | MEDLINE/PubMed |
spelling | pubmed-71178202020-04-03 Faut-il contrôler la fièvre dans les infections sévères ? Seguin, P. Launey, Y. Nesseler, N. Malledant, Y. Reanimation Mise au Point / Update Temperature control during severe sepsis is currently used in intensive care and involves 66% and 70% of severe sepsis and septic shock, respectively. Nevertheless, the conclusive evidence of the benefit of such a strategy is still lacking.We might wonder, with regards to experimental works and recent noninterventional studies, about the risk of a control strategy on an ongoing infectious process, the patient’s outcome, and the safety of the means implemented to obtain temperature control. On the other hand, it is also demonstrated that fever increases oxygen consumption, which may lead in some clinical situations to tissular ischemia and that fever may be associated with a deleterious focal inflammatory process. Methods to control the temperature include external and/or internal cooling and/or antipyretic medications such as paracetamol and nonsteroidal antiinflammatory drugs. In septic patients, external cooling and paracetamol are the mains means used to control temperature. Despite the uncertainties about the benefit to control or not the temperature, it could be stated that extreme temperature (hypo- or hyperthermia) should be avoided and that the benefit/risk of temperature control must be individually weighted. Lavoisier 2016-03-11 2016 /pmc/articles/PMC7117820/ /pubmed/32288743 http://dx.doi.org/10.1007/s13546-015-1168-x Text en © Société de réanimation de langue française (SRLF) and Springer-Verlag France 2015 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Mise au Point / Update Seguin, P. Launey, Y. Nesseler, N. Malledant, Y. Faut-il contrôler la fièvre dans les infections sévères ? |
title | Faut-il contrôler la fièvre dans les infections sévères ? |
title_full | Faut-il contrôler la fièvre dans les infections sévères ? |
title_fullStr | Faut-il contrôler la fièvre dans les infections sévères ? |
title_full_unstemmed | Faut-il contrôler la fièvre dans les infections sévères ? |
title_short | Faut-il contrôler la fièvre dans les infections sévères ? |
title_sort | faut-il contrôler la fièvre dans les infections sévères ? |
topic | Mise au Point / Update |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117820/ https://www.ncbi.nlm.nih.gov/pubmed/32288743 http://dx.doi.org/10.1007/s13546-015-1168-x |
work_keys_str_mv | AT seguinp fautilcontrolerlafievredanslesinfectionsseveres AT launeyy fautilcontrolerlafievredanslesinfectionsseveres AT nesselern fautilcontrolerlafievredanslesinfectionsseveres AT malledanty fautilcontrolerlafievredanslesinfectionsseveres |